30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Smith & Nephew 2016 Revenue -

ORTHOWORLD estimates Smith & Nephew 2016 orthopaedic revenue of US $3,250.5MM, +2.8% from 2015, with 4Q16 revenue of $854.9MM, -1.3% vs. 4Q15.

ORTHOWORLD estimates 2016 segment sales and growth on an as-reported basis, as follows.

  • Joint Reconstruction $1,609.8MM, +4.7%
    • Hip $597.0MM, -1.2%
    • Knee $960.5MM, +8.8%
    • Extremities $52.3MM, +3.4%
  • Trauma $422.8MM, -5.4%
  • Arthroscopy/Soft Tissue $1,218.0MM, +3.3%


  • Hips and knees affected by fewer sales days year over year
  • Moving to broader launch of ANTHEM total knee, developed to suit patient anatomies in Asia, Middle East, Africa and Latin America
  • eCAP initiative garnering strong customer interest
  • Syncera model still capturing business
  • NAVIO revenue +50% over prior year, as expected; sold first system in India during 4Q; noted that ZUK uni knee performing well with Blue Belt robotics
  • Trauma, Extremities impacted by fewer sales days and trading conditions in Gulf states, countered by strong U.S. performance following campaign for TRIGEN INTERTAN hip nail
  • Growth in Arthroscopy/Soft Tissue Repair supported by shoulder, knee and hip repair, though some softness in mechanical resection
  • Specific products supporting growth include LENS Surgical Imaging, WEREWOLF Coblation, ULTRABUTTON Adjustable Fixation Device, limited market launch of JOURNEY II XR bi-cruciate retaining knee, REDAPT Revision System
  • Will move manufacture of WEREWOLF system to Costa Rica facility in the future

Sources: Smith & Nephew plc; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.